-
公开(公告)号:US11136390B2
公开(公告)日:2021-10-05
申请号:US15735947
申请日:2016-06-11
Applicant: ALECTOR LLC
Inventor: Kate Monroe , Helen Lam , Francesca Avogadri-Connors , Seung-Joo Lee , William Monteith , Herve Rhinn , Arnon Rosenthal
Abstract: The present disclosure is generally directed to compositions that include antibodies, e.g., monoclonal, chimeric, humanized antibodies, antibody fragments, etc., that specifically bind one or more epitopes within a CD33 protein, e.g., human CD33 or a mammalian CD33, and use of such compositions in preventing, reducing risk, or treating an individual in need thereof.
-
公开(公告)号:US20190040131A1
公开(公告)日:2019-02-07
申请号:US16054840
申请日:2018-08-03
Applicant: ALECTOR LLC
Inventor: Patricia Culp , Helen Lam , Arnon Rosenthal , Seung-Joo Lee , Nels P. Nielson , Robert Pejchal
Abstract: The present disclosure is generally directed to compositions that include antibodies, e.g., monoclonal, chimeric, humanized antibodies, antibody fragments, etc., that specifically bind one or more epitopes within a CD33 protein, e.g., human CD33 or a mammalian CD33, and have improved and/or enhanced functional characteristics, and use of such compositions in preventing, reducing risk, or treating an individual in need thereof.
-
公开(公告)号:US12247073B2
公开(公告)日:2025-03-11
申请号:US17272083
申请日:2019-08-30
Applicant: Alector LLC
Inventor: Patricia Culp , Helen Lam , Wei-Hsien Ho , Leonard G. Presta , Arnon Rosenthal
IPC: C07K16/28
Abstract: The present disclosure is generally directed to compositions that include antibodies, e.g., monoclonal, antibodies, antibody fragments, etc., that specifically bind a CD33 polypeptide, e.g., a mammalian CD33 or human CD33, and use of such compositions in preventing, reducing risk, or treating an individual in need thereof.
-
公开(公告)号:US20230121869A1
公开(公告)日:2023-04-20
申请号:US17931757
申请日:2022-09-13
Applicant: Alector LLC
Inventor: Andrew Pincetic , Arnon Rosenthal , Helen Lam , Francesca Avogadri-Connors , Seung-Joo Lee
IPC: C07K16/28
Abstract: The present disclosure is generally directed to compositions that include antibodies, e.g., monoclonal, chimeric, humanized antibodies, antibody fragments, etc., that specifically bind a TREM1 protein, e.g., a mammalian TREM1 or human TREM1, and use of such compositions in preventing, reducing risk, or treating an individual in need thereof.
-
公开(公告)号:US11084875B2
公开(公告)日:2021-08-10
申请号:US16382117
申请日:2019-04-11
Applicant: ALECTOR LLC
Inventor: Kate Monroe , Tina Schwabe , Francesca Avogadri-Connors , Ilaria Tassi , Helen Lam , Arnon Rosenthal
Abstract: The invention is generally directed to methods and compositions that include antibodies, e.g., monoclonal, chimeric, humanized antibodies, antibody fragments, etc., that specifically bind a TREM2 protein, e.g., a mammalian TREM2 and/or human TREM2. The methods provided herein find use in preventing, reducing risk, or treating an individual having dementia, frontotemporal dementia, Alzheimer's disease, Nasu-Hakola disease, or multiple sclerosis.
-
公开(公告)号:US10711062B2
公开(公告)日:2020-07-14
申请号:US16054840
申请日:2018-08-03
Applicant: ALECTOR LLC
Inventor: Patricia Culp , Helen Lam , Arnon Rosenthal , Seung-Joo Lee , Nels P. Nielson , Robert Pejchal
Abstract: The present disclosure is generally directed to compositions that include antibodies, e.g., monoclonal, chimeric, humanized antibodies, antibody fragments, etc., that specifically bind one or more epitopes within a CD33 protein, e.g., human CD33 or a mammalian CD33, and have improved and/or enhanced functional characteristics, and use of such compositions in preventing, reducing risk, or treating an individual in need thereof.
-
-
-
-
-